646| 93
|
INDAR劳拉替尼(Lorlatinib)填补平价肺癌耐药后市场空白 |
提示: 作者被禁止或删除 内容自动屏蔽
| |
| ||
| ||
联系站长QQ:5131834|Archiver|手机版|自媒体论坛
GMT+8, 2024-5-6 09:34 , Processed in 0.259097 second(s), 19 queries .
Powered by Discuz! X2.5
© 2001-2012 Comsenz Inc.